KR100779819B1 - The stability technology of using the technology of the liposome including kinetin which is effective for anti-wrinkle and the components of cosmetics including the liposome and the method of manufacturing the components. - Google Patents
The stability technology of using the technology of the liposome including kinetin which is effective for anti-wrinkle and the components of cosmetics including the liposome and the method of manufacturing the components. Download PDFInfo
- Publication number
- KR100779819B1 KR100779819B1 KR1020060002557A KR20060002557A KR100779819B1 KR 100779819 B1 KR100779819 B1 KR 100779819B1 KR 1020060002557 A KR1020060002557 A KR 1020060002557A KR 20060002557 A KR20060002557 A KR 20060002557A KR 100779819 B1 KR100779819 B1 KR 100779819B1
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- kinetin
- total weight
- amount
- contained
- Prior art date
Links
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 title claims abstract description 81
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 title claims abstract description 81
- 229960001669 kinetin Drugs 0.000 title claims abstract description 81
- 239000002502 liposome Substances 0.000 title claims abstract description 46
- 239000002537 cosmetic Substances 0.000 title claims abstract description 42
- 238000004519 manufacturing process Methods 0.000 title claims description 15
- 230000001153 anti-wrinkle effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 claims abstract description 69
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 21
- 239000000787 lecithin Substances 0.000 claims abstract description 21
- 229940067606 lecithin Drugs 0.000 claims abstract description 21
- 235000010445 lecithin Nutrition 0.000 claims abstract description 21
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229940106189 ceramide Drugs 0.000 claims abstract description 11
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims abstract description 10
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims abstract description 10
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims abstract description 10
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims abstract description 10
- 230000001804 emulsifying effect Effects 0.000 claims abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000004310 lactic acid Substances 0.000 claims description 9
- 235000014655 lactic acid Nutrition 0.000 claims description 9
- 239000006210 lotion Substances 0.000 claims description 9
- 235000016709 nutrition Nutrition 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- 239000006071 cream Substances 0.000 claims description 6
- 229960000448 lactic acid Drugs 0.000 claims description 6
- 230000035764 nutrition Effects 0.000 claims description 6
- 239000008213 purified water Substances 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 229920005615 natural polymer Polymers 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 5
- 230000009759 skin aging Effects 0.000 abstract description 4
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 230000035515 penetration Effects 0.000 abstract description 3
- 230000004075 alteration Effects 0.000 abstract 1
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 abstract 1
- 239000002994 raw material Substances 0.000 description 90
- 239000000243 solution Substances 0.000 description 40
- 230000000052 comparative effect Effects 0.000 description 20
- 150000002632 lipids Chemical class 0.000 description 12
- 239000008346 aqueous phase Substances 0.000 description 10
- 238000009472 formulation Methods 0.000 description 10
- 239000000839 emulsion Substances 0.000 description 9
- 238000004945 emulsification Methods 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 4
- 238000013112 stability test Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 3
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 3
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 3
- 239000002211 L-ascorbic acid Substances 0.000 description 3
- 235000000069 L-ascorbic acid Nutrition 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 3
- 235000017471 coenzyme Q10 Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- JGPMMRGNQUBGND-UHFFFAOYSA-N idebenone Chemical compound COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O JGPMMRGNQUBGND-UHFFFAOYSA-N 0.000 description 3
- 229960004135 idebenone Drugs 0.000 description 3
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 3
- 235000019136 lipoic acid Nutrition 0.000 description 3
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229960002663 thioctic acid Drugs 0.000 description 3
- 229960000984 tocofersolan Drugs 0.000 description 3
- 229940035936 ubiquinone Drugs 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- -1 ziitol Polymers 0.000 description 1
Images
Classifications
-
- E—FIXED CONSTRUCTIONS
- E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
- E02B—HYDRAULIC ENGINEERING
- E02B3/00—Engineering works in connection with control or use of streams, rivers, coasts, or other marine sites; Sealings or joints for engineering works in general
- E02B3/04—Structures or apparatus for, or methods of, protecting banks, coasts, or harbours
- E02B3/12—Revetment of banks, dams, watercourses, or the like, e.g. the sea-floor
- E02B3/129—Polyhedrons, tetrapods or similar bodies, whether or not threaded on strings
-
- E—FIXED CONSTRUCTIONS
- E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
- E02B—HYDRAULIC ENGINEERING
- E02B3/00—Engineering works in connection with control or use of streams, rivers, coasts, or other marine sites; Sealings or joints for engineering works in general
- E02B3/04—Structures or apparatus for, or methods of, protecting banks, coasts, or harbours
- E02B3/06—Moles; Piers; Quays; Quay walls; Groynes; Breakwaters ; Wave dissipating walls; Quay equipment
- E02B3/08—Structures of loose stones with or without piles
Landscapes
- Engineering & Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Environmental & Geological Engineering (AREA)
- Ocean & Marine Engineering (AREA)
- Mechanical Engineering (AREA)
- Civil Engineering (AREA)
- Structural Engineering (AREA)
- Cosmetics (AREA)
Abstract
본 발명에 따르면 피부노화억제에 효과적인 키네틴함유 리포좀을 함유하는 화장료 조성물 및 그의 제조방법이 제공되며, 본 발명의 화장료 조성물은 총 조성물 중량의 1.0-10.0%의 레시틴, 조성물 총 중량의 0.1-2.0%의 세라마이드, 조성물 총 중량의 0.1-40.0%의 락틱애씨드와 조성물 총 중량의 0.01-2.0%의 키네틴으로 이루어진 리포좀, 조성물 총 중량의 0.1%-40.0%의 유화안정보조제로서의 프로필렌글리콜을 함유한다.According to the present invention, there is provided a cosmetic composition containing a kinetin-containing liposome effective for inhibiting skin aging, and a method for preparing the same, wherein the cosmetic composition of the present invention is 1.0-10.0% of the total composition weight, and 0.1-2.0% of the total weight of the composition. Ceramide, liposome consisting of 0.1-40.0% lactide of the total weight of the composition and 0.01-2.0% kinetin of the total weight of the composition, and propylene glycol as 0.1% -40.0% of the emulsifying stability aid of the total weight of the composition.
상기와 같은 화장료 조성물은 키네틴을 장기간 안정하게 활성의 손실이나 변질없이 유지할 수 있으며, 키네틴의 피부에의 침투력이 우수하기 때문에 키네틴에 의한 피부 미용효과를 충분히 발휘할 수 있다.The cosmetic composition as described above can maintain the kinetin stably for a long time without loss of activity or alteration, and can exhibit sufficient skin cosmetic effects by kinetin because of its excellent penetration into the skin.
레시틴, 세라마이드, 키네틴, 리포좀, 고압균질기 Lecithin, ceramide, kinetin, liposome, autoclave
Description
제1도는 항산화제인 아이데베논(Idebenone), 토코페롤(DL-α-tocopherol), 키네틴(Kinetin), 유비퀴논(Ubiquinone), 비타민 씨(L-ascorbic acid) 및 리포익애씨드(DL-α-lipoic-acid)의 자외선에 의한 피부의 손상감소(Sunburn cell reduction)를 나타낸다.(Reference: the Annual Meeting of the American Academy of Dermatology ; February 6-11, 2004 ; Washington, D.C.(Acknowledgment : Pharma Cosmetix Research, Richmond, Va)).Figure 1 shows antioxidants Idebenone, DL-α-tocopherol, Kinetin, Ubiquinone, L-ascorbic acid and Lipoic acid DL-α-lipoic- sunburn cell reduction due to ultraviolet rays of acid. (Reference: the Annual Meeting of the American Academy of Dermatology; February 6-11, 2004; Washington, DC (Acknowledgment: Pharma Cosmetix Research, Richmond, Va)).
제2도는 항산화제인 아이데베논(Idebenone), 토코페롤(DL-α-tocopherol), 키네틴(Kinetin), 유비퀴논(Ubiquinone), 비타민 씨(L-ascorbic acid) 및 리포익애씨드(DL-α-lipoic-acid)의 지질의 과산화 방지효과(Protection against lipid peroxidation over 24 hours)를 나타낸다.(Reference: the Annual Meeting of the American Academy of Dermatology ; February 6-11, 2004 ; Washington, D.C.(Acknowledgment : Pharma Cosmetix Research, Richmond, Va)).Figure 2 shows antioxidants Idebenone, DL-α-tocopherol, Kinetin, Ubiquinone, L-ascorbic acid and Lipoic acid DL-α-lipoic- (Reference: the Annual Meeting of the American Academy of Dermatology; February 6-11, 2004; Washington, DC (Acknowledgment: Pharma Cosmetix Research, Richmond, Va)).
제3도는 항산화제인 아이데베논(Idebenone), 토코페롤(DL-α-tocopherol), 키네틴(Kinetin), 유비퀴논(Ubiquinone), 비타민 씨(L-ascorbic acid) 및 리포익애씨드(DL-α-lipoic-acid)의 세포내 지질의 산화방지효과(Protection against oxidation of the cell membrane lipids)를 나타낸다.(Reference: the Annual Meeting of the American Academy of Dermatology ; February 6-11, 2004 ; Washington, D.C.(Acknowledgment : Pharma Cosmetix Research, Richmond, Va)).FIG. 3 shows antioxidants Idebenone, DL-α-tocopherol, Kinetin, Ubiquinone, L-ascorbic acid and Lipoic acid DL-α-lipoic- (Reference: the Annual Meeting of the American Academy of Dermatology; February 6-11, 2004; Washington, DC (Acknowledgment: Pharma) Cosmetix Research, Richmond, Va)).
본 발명은 피부노화억제에 효과적인 키네틴의 리포좀 기법을 이용한 안정화 기술 및 이를 함유하는 화장료 조성물과 그의 제조 방법에 관한 것이다.The present invention relates to a stabilization technique using liposome technique of kinetin effective in inhibiting skin aging, and a cosmetic composition containing the same and a method for producing the same.
최근 피부노화 지연 등을 목적으로 한 특정의 생리활성 물질을 함유하는 기능성 화장료에 대한 관심이 높아지고 또 많은 연구가 행해지고 있다. 본 발명도 이러한 기능성 화장료에 관한 것으로서 피부 내 프리래디컬로부터 세포를 보호하여 피부노화를 억제하는 기능을 갖는 키네틴을 함유하는 화장료 조성물이다. 본 발명의 화장료 조성물에 배합되는 키네틴은 자외선이나 여러 원인에 의하여 발생된 프리래디컬의 활성을 억제하여 피부의 노화지연 기능을 나타낸다.In recent years, interest in functional cosmetics containing specific bioactive substances for the purpose of delaying skin aging, etc. has been increasing and many studies have been conducted. The present invention also relates to such a functional cosmetic composition, which is a cosmetic composition containing kinetin having a function of protecting cells from free radicals in the skin and inhibiting skin aging. Kinetine blended in the cosmetic composition of the present invention suppresses the activity of free radicals caused by ultraviolet rays or various causes, thereby exhibiting a aging delay function of the skin.
이러한 키네틴의 항산화 기능을 화장료에 응용하기 위하여 키네틴을 화장료에 첨가한 화장료가 제안된바 있다. 그러나 종래의 화장료들은 화장료 조성물에 키네틴을 단순히 첨가하여 제조한 단순유화 타입 또는 젤 타입의 제품들로서 화장료 내에 충분한 양의 키네틴을 배합하기가 어렵고, 또한 화장료 내에 함유된 키네틴이 화장료 보존시 침전되어 적용 등에 한계가 있는 결점을 갖고 있다. 그 이유로는 일반물질은 정제수나 오일에 용해되나 키네틴은 정제수나 오일에 거의 녹지 않고 알콜에만 매우 적은 양이 용해되므로 화장료에 적용하여도 장기적인 안정도를 관찰해보면 분리현상이나 침전현상이 발생되어 적정량의적용이 어려운 상황이다.In order to apply the antioxidant function of kinetin to cosmetics, cosmetics in which kinetin is added to cosmetics have been proposed. However, conventional cosmetics are simple emulsified type or gel type products prepared by simply adding kinetin to the cosmetic composition, and it is difficult to blend sufficient amounts of kinetin in the cosmetics, and also, kinetin contained in the cosmetics is precipitated during cosmetic preservation and applied. It has its limitations. For this reason, general substances are dissolved in purified water or oil, but kinetin is hardly dissolved in purified water or oil, and only a very small amount is dissolved in alcohol. Therefore, even when applied to cosmetics, separation or sedimentation may occur, and an appropriate amount may be applied. This is a difficult situation.
한편, 리포좀 화장료의 경우에도 키네틴의 용해도가 낮아 침전이 발생하므로 리포좀의 장점인 피부침투력을 기대하기 어려운 상황이므로 처방 시에 용매를 선택해야 하는 문제점이 있었다.On the other hand, even in the case of liposome cosmetics, because the solubility of kinetin is low, precipitation occurs, so it is difficult to expect skin penetration, which is an advantage of liposomes.
이러한 상황 하에서 본 발명자들은 상기한 문제점을 갖지 않고 피부 침투력이 우수하며 장기간 활성의 손실 없이 안정하게 보존할 수 있는 키네틴-함유 화장료의 조성물을 제공하고자 예의 연구한 결과 키네틴을 락틱애씨드나 알파하이드록시애씨드로 용해한 다음 리포좀화하여 이것을 화장료에 첨가하므로써 상기 목적을 달성할 수 있음을 발견하고 본 발명을 완성하기에 이르렀다.Under these circumstances, the inventors of the present invention have studied intensively to provide a composition of a kinetin-containing cosmetic composition that does not have the above-mentioned problems and has excellent skin penetration and can be stably preserved without losing long-term activity. The present invention has been accomplished by discovering that the above object can be achieved by dissolving into liposomes and adding the same to cosmetics.
즉, 본 발명의 목적은 총 조성물 중량의 1.0-10.0%의 레시틴, 조성물 총 중량의 0.1-2.0%의 세라마이드, 조성물 총 중량의 0.1-40.0%의 락틱애씨드와 조성물 총 중량의 0.01-2.0%의 키네틴으로 이루어진 리포좀을 함유함을 특징으로 하는 키네핀 함유화장료 조성물을 제공하는 것이다.That is, an object of the present invention is 1.0-10.0% of the total composition weight of lecithin, 0.1-2.0% of the ceramide of the total weight of the composition, 0.1-40.0% of the total weight of the composition and 0.01-2.0% of the total weight of the composition It is to provide a kinepin-containing cosmetic composition characterized in that it contains a liposome consisting of kinetin.
본 발명의 또 다른 목적은 정제수, 레시틴, 세라마이드, 락틱애씨드 및 키네틴을 함유하는 혼합물을 고압균질기(High Pressure Homogenizer)에 통과시켜 키네 틴 함유 리포좀이 고르게 분산된 화장료 조성물의 제조방법을 제공하는 것이다.Still another object of the present invention is to provide a method for preparing a cosmetic composition in which kinetin-containing liposomes are evenly dispersed by passing a mixture containing purified water, lecithin, ceramide, lactic acid and kinetin through a high pressure homogenizer. .
이하 본 발명을 보다 상세히 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명에 따라 제공하는 화장료 조성물은 리포좀 화된 키네틴을 함유하기 때문에 키네틴의 경피흡수성이 매우 뛰어나며 키네틴의 활성이 손실되는 일 없이 장기간 안정하게 보존할 수 있다.Since the cosmetic composition provided according to the present invention contains liposome-ized kinetin, it is very excellent in percutaneous absorption of kinetin and can be stably stored for a long time without losing the activity of kinetin.
본 발명에서 리포좀 화시킬 키네틴과 접촉하여 키네틴을 함유하는 리포좀을 형성하기 위한 물질로는 레시틴이 사용되며, 조성물 총 중량에 대하여 1.0%-10.0%의 양으로 사용된다.In the present invention, as a substance for forming liposomes in contact with the kinetin to be liposomed, lecithin is used, and is used in an amount of 1.0% -10.0% based on the total weight of the composition.
본 발명에서 사용되는 세라마이드는 조성물 총 중량에 대하여 0.1-2.0%의 양으로 사용된다.The ceramides used in the present invention are used in amounts of 0.1-2.0% based on the total weight of the composition.
본 발명에서 키네틴의 용해도를 높이기 위해 락틱애씨드나 알파하이드록시애씨드가 사용되며 조성물 총 중량에 대하여 0.1-40.0%의 양으로 사용된다.In the present invention, lactic acid or alpha hydroxy acid is used to increase the solubility of kinetin and is used in an amount of 0.1-40.0% based on the total weight of the composition.
본 발명의 화장료 조성물은 키네틴을 안정화시키기 위해 유화안정 보조제를 함유할 수 있으며, 예를 들면 프로필렌글리콜, 부틸렌글리콜, 글리세린, 자이리톨, 천연 고분자 화합물 등의 폴리머를 조성물 총 중량에 대하여 0.1-20.0%의 양으로 사용할 수 있다.The cosmetic composition of the present invention may contain an emulsification stabilizer to stabilize the kinetin, for example, a polymer such as propylene glycol, butylene glycol, glycerin, ziitol, natural polymer compound, 0.1-20.0% based on the total weight of the composition Can be used in amounts.
본 발명의 방법에 따르면, 먼저 정제수, 트윈 60을 70-80도에서 호모믹서로 교반하여 식힌 후 온도를 40도정도 유지하여 균질의 수용액을 만든다. 한편, 락틱애씨드에 키네틴을 상온에서 용해시켜 키네틴용액을 만들고 레시틴과 세라마이드를 40도에서 프로필렌글리콜로 용해시켜 레시틴용액을 만든 후 키네틴용액을 레시틴용 액에 서서히 첨가하여 호모믹서로 균질화 시킨 후 먼저 준비한 수용액에 서서히 첨가하여 유화 액을 얻는다. 얻어진 유화 액을 고압균질기에 통과시켜 키네틴함유 리포좀을 고르게 분산시킨 유화 액을 얻는다.According to the method of the present invention, first, purified water, Tween 60 is stirred with a homomixer at 70-80 degrees, cooled, and maintained at about 40 degrees to make a homogeneous aqueous solution. Meanwhile, kinetin is dissolved in lactic acid at room temperature to make kinetin solution, and lecithin and ceramide are dissolved in propylene glycol at 40 ° C to make lecithin solution. It is slowly added to an aqueous solution to obtain an emulsion. The obtained emulsion is passed through a high pressure homogenizer to obtain an emulsion in which the kinetin-containing liposome is evenly dispersed.
이상과 같은 본 발명의 방법에 의하여 종래 화장품에서 사용되어지던 키네틴을 보다 안정하고 활성의 손실 없이 화장료에 배합하고 또한 피부에 적용 시에 침투성을 향상시킴으로써 키네틴이 갖는 항산화기능을 충분히 발휘할 수 있는 유화타입의 화장료를 제공하는 것이 가능하여졌다.Emulsion type capable of fully exhibiting the antioxidant function of kinetin by blending kinetin, which has been conventionally used in cosmetics, in cosmetics without loss of activity and improving permeability when applied to skin by the method of the present invention as described above. It was possible to provide cosmetics.
이하 실시 예를 통하여 본 발명을 보다 상세히 설명하지만 본 발명이 이들 실시예에만 국한되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the following Examples, but the present invention is not limited to these Examples.
표 1. 실시예 1 및 비교예 1Table 1. Example 1 and Comparative Example 1
제조방법Manufacturing method
실시예 1 : 원료물질 1,2,3,12 및 13을 70-80도에서 혼합하고 균질 화하여 수상이라 칭한다. 원료물질 4를 원료물질 5에 25도에서 용해시키고 규질 화하여 키네틴용액이라 칭한다. 원료물질 9 및 10을 40도에서 원료물질 11에 용해시키고 균질화하여 레시틴 용액이라 칭한다. 상기 키네틴용액과 레시틴용액을 30-40도에서 혼합하여 균질 화시켜 리포좀 용액이라 칭한다. 상기 수상과 리포좀 용액을 30-40도에서 서서히 혼합한 후 고압균질기(High Pressure Homogenizer)를 통과하여 키네틴-함유 리포좀이 균일하게 분산된 유화 액을 얻어 안정화 시킨 후 2-7일간 숙성시킨다.Example 1 Raw materials 1,2,3,12 and 13 are mixed and homogenized at 70-80 degrees to be called an aqueous phase. The raw material 4 is dissolved in the raw material 5 at 25 degrees and silicified to be referred to as a kinetin solution. The
비교예 1 : 원료물질 1,6,12 및 13을 70-80도에서 혼합하고 균질 화하여 수상이라 칭한다. 원료물질 4를 원료물질 7에 40도에서 용해시키고 규질 화하여 키네틴용액이라 칭한다. 수상에 40-45도에서 키네틴용액을 혼합하여 균질 화하고 원료물질 8을 첨가한 후 2-7일간 숙성시킨다.Comparative Example 1: The raw materials 1, 6, 12 and 13 are mixed at 70-80 degrees and homogenized to be called an aqueous phase. The raw material 4 is dissolved in the raw material 7 at 40 degrees and silicified to be referred to as a kinetin solution. The mixture is homogenized by mixing the kinetin solution at 40-45 ° C in the water phase, and aged for 2-7 days after adding the raw material 8.
표 2. 실시예 2 및 비교예 2Table 2. Example 2 and Comparative Example 2
제조방법Manufacturing method
실시예 2 : 원료물질 1,2,3,12 및 13을 70-80도에서 혼합하고 균질 화하여 수상이라 칭한다. 원료물질 4를 원료물질 5에를 25도에서 용해시키고 규질 화하여 키네틴 용액이라 칭한다. 원료물질 9 및 10을 40도에서 원료물질 11에 용해시키고 균질 화하여 레시틴 용액이라 칭한다. 상기 키네틴용액과 레시틴용액을 30-40도에서 혼합하여 균질 화시켜 리포좀 용액이라 칭한다. 상기 수상과 리포좀 용액을 30-40도에서 서서히 혼합한 후 고압균질기(High Pressure Homogenizer)를 통과하여 키 네틴-함유 리포좀이 균일하게 분산된 유화 액을 얻어 안정화 시킨 후 2-7일간 숙성시킨다.Example 2 Raw materials 1,2,3,12 and 13 are mixed and homogenized at 70-80 degrees to be called water phase. The raw material 4 is dissolved in a raw material 5 at 25 degrees and silicified to be referred to as a kinetin solution. The
비교예 2 : 원료물질 1,6,12 및 13을 70-80도에서 흔합하고 균질 화하여 수상이라 칭한다. 원료물질 4를 원료물질 7에 40도에서 용해시키고 규질 화하여 키네틴용액이라 칭한다. 수상에 40-45도에서 키네틴용액을 혼합하여 균질 화하고 원료물질 8을 첨가한 후 2-7일간 숙성시킨다.Comparative Example 2: Raw materials 1, 6, 12 and 13 were mixed at 70-80 degrees and homogenized to be called water phases. The raw material 4 is dissolved in the raw material 7 at 40 degrees and silicified to be referred to as a kinetin solution. The mixture is homogenized by mixing the kinetin solution at 40-45 ° C in the water phase, and aged for 2-7 days after adding the raw material 8.
표 3. 실시예 3 및 비교예 3Table 3. Example 3 and Comparative Example 3
제조방법Manufacturing method
실시예 3 : 원료물질 1,2,3,12 및 13을 70-80도에서 혼합하고 균질 화하여 수상이라 칭한다. 원료물질 4를 원료물질 5에를 25도에서 용해시키고 규질 화하여 키네틴 용액이라 칭한다. 원료물질 9 및 10을 40도에서 원료물질 11에 용해시키고 균질 화하여 레시틴 용액이라 칭한다. 상기 키네틴용액과 레시틴용액을 30-40도에서 혼합하여 균질 화시켜 리포좀 용액이라 칭한다. 상기 수상과 리포좀 용액을 30-40도에서 서서히 혼합한 후 고압균질기(High Pressure Homogenizer)를 통과하여 키네틴-함유 리포좀이 균일하게 분산된 유화 액을 얻어 안정화 시킨 후 2-7일간 숙성시킨다.Example 3 Raw materials 1,2,3,12 and 13 are mixed and homogenized at 70-80 degrees to be called an aqueous phase. The raw material 4 is dissolved in a raw material 5 at 25 degrees and silicified to be referred to as a kinetin solution. The
비교예 3 : 원료물질 1,6,12 및 13을 70-80도에서 혼합하고 균질 화하여 수상이라 칭한다. 원료물질 4를 원료물질 7에 40도에서 용해시키고 규질 화하여 키네틴용액이라 칭한다. 수상에 40-45도에서 키네틴용액을 혼합하여 균질 화하고 원료물질 8을 첨가한 후 2-7일간 숙성시킨다.Comparative Example 3: The raw materials 1, 6, 12 and 13 are mixed and homogenized at 70-80 degrees to be called an aqueous phase. The raw material 4 is dissolved in the raw material 7 at 40 degrees and silicified to be referred to as a kinetin solution. The mixture is homogenized by mixing the kinetin solution at 40-45 ° C in the water phase, and aged for 2-7 days after adding the raw material 8.
표 4. 실시예 4 및 비교예 4Table 4. Example 4 and Comparative Example 4
제조방법Manufacturing method
실시예 4 : 통상의 단순 유화방법에 따라 원료물질 1,6,7 및 8을 70-80도에서 혼합하고 원료물질 5를 첨가하여 잘 혼합한 후 40-45도에서 나머지 원료물질인 4을 혼합하여 2-7일간 숙성시킨다.Example 4 According to a conventional simple emulsification method, the raw materials 1, 6, 7 and 8 are mixed at 70-80 degrees, and the raw materials 5 are added and mixed well, and then the remaining raw materials 4 are mixed at 40-45 degrees. It is aged for 2-7 days.
비교예 4 : 원료물질 3에 원료물질 2를 40-50도에서 용해하여 균질 화시켜 이를 키네틴 용액이라 칭한다. 통상의 단순 유화방법에 따라 원료물질 1,6,7 및 8을 70-80도에서 혼합하고 원료물질 5를 첨가하여 잘 혼합한 후 40-45도에서 키네틴 용액을 혼합하여 2-7일간 숙성시킨다.Comparative Example 4: The raw material 2 is dissolved in the raw material 3 at 40-50 degrees to homogenize, and this is called a kinetin solution. The raw materials 1, 6, 7 and 8 are mixed at 70-80 degrees according to the conventional simple emulsification method, the raw materials 5 are mixed well, and the kinetin solution is mixed at 40-45 degrees and aged for 2-7 days. .
표 5. 실시예 5 및 비교예 5Table 5. Example 5 and Comparative Example 5
제조방법Manufacturing method
실시예 5 : 원료물질 1,2,3,10 및 11을 70-80도에서 혼합하고 균질 화하여 수상이라 칭한다. 원료물질 4를 원료물질 5에 25도에서 용해시키고 규질 화하여 키네틴용액이라 칭한다. 원료물질 7 및 8을 40도에서 원료물질 9에 용해시키고 균질 화하여 레시틴 용액이라 칭한다. 상기 키네틴용액과 레시틴용액을 30-40도에서 혼합하여 균질 화시켜 리포좀 용액이라 칭한다. 상기 수상과 리포좀 용액을 30-40도에서 서서히 혼합한 후 고압균질기(High Pressure Homogenizer)를 통과하여 키네틴-함유 리포좀이 균일하게 분산된 유화 액을 얻어 안정화 시킨 후 2-7일간 숙성시킨 다.Example 5
비교예 5 : 원료물질 1,2,3,10 및 11을 70-80도에서 혼합하고 균질 화하여 수상이라 칭한다. 원료물질 4를 원료물질 6에 40도에서 용해시키고 규질 화하여 키네틴용액이라 칭한다. 원료물질 7 및 8을 40도에서 원료물질 9에 용해시키고 균질 화하여 레시틴 용액이라 칭한다. 상기 키네틴용액과 레시틴용액을 30-40도에서 혼합하여 균질 화시켜 리포좀 용액이라 칭한다. 상기 수상과 리포좀 용액을 30-40도에서 서서히 혼합한 후 고압균질기(High Pressure Homogenizer)를 통과하여 키네틴-함유 리포좀이 균일하게 분산된 유화 액을 얻어 안정화 시킨 후 2-7일간 숙성시킨다.Comparative Example 5: The
[원심분리안정성시험][Centrifuge Stability Test]
상기의 실시 예 및 비교 예에 따라 제조된 제품들의 원심분리 안정성을 알아보기 위하여 제품을 각 500g씩 제조하여 적량씩 취하여 4000 RPM에서 10분, 8000 RPM에서 10분 및 12000 RPM에서 10분간 원심 분리하여 얻어진 결과를 표에 나타내었다.In order to determine the centrifugation stability of the products manufactured according to the above examples and comparative examples, 500g of each product was prepared and taken in an appropriate amount, followed by centrifugation at 10 minutes at 4000 RPM, 10 minutes at 8000 RPM, and 10 minutes at 12000 RPM. The results obtained are shown in the table.
표 6. 원심분리안정성 시험결과Table 6. Centrifuge Stability Test Results
상기 표의 원심분리안정성 시험결과에서 알 수 있는 바와 같이, 리포좀 기법을 이용하여 키네틴을 안정화시킨 화장료 조성물을 함유한 실시예 1,2,3 및 4는 일반유화 기법으로 키네틴을 함유한 비교예 1,2,3 및 4에 비하여 원심분리 안정성에 문제가 없는 것으로 확인되었다.As can be seen from the results of the centrifugation stability test of the table, Examples 1, 2, 3 and 4 containing the cosmetic composition stabilized kinetin using liposome technique are Comparative Examples 1, containing kinetin by general emulsification technique. It was confirmed that there is no problem in the centrifugation stability as compared to 2, 3 and 4.
또한, 락틱애씨드를 키네틴의 용매로 사용한 실시예 5는 에틸알콜을 키네틴의 용매로 사용한 비교예 5에 비하여 원심분리 안전성에 문제가 없는 것으로 확인되었다.In addition, Example 5 using the lactic acid as the solvent of kinetin was confirmed that there is no problem in the centrifugation safety compared to Comparative Example 5 using ethyl alcohol as the solvent of kinetin.
[경시안정성시험][Cyancular Qualitative Test]
상기의 실시예 및 비교 예에 따라 제조된 제품들의 경시 안정성을 알아보기 위하여 제품을 각 500g씩 제조하여 투명유리용기에 담아서 실온(25도), 고온(40도), 일광에 보관하고 얻어진 결과를 표에 나타내었다.In order to examine the stability over time of the products manufactured according to the above examples and comparative examples, 500g of each product was prepared and placed in a transparent glass container and stored at room temperature (25 °), high temperature (40 °), and daylight. Shown in the table.
표 7. 경시안정성 시험결과Table 7. Time-lapse test results
상기 표의 경시안정성 시험결과에서 알 수 있는 바와 같이, 리포좀 기법을 이용하여 키네틴을 안정화시킨 화장료 조성물을 함유한 실시예 1,2,3 및 4는 일반유화 기법으로 키네틴을 함유한 실시예 1,2,3 및 4에 비하여 경시보관 안정성에도 문제가 없는 것으로 확인되었다.As can be seen from the results of chronological stability test of the table, Examples 1, 2, 3, and 4 containing the cosmetic composition stabilized kinetin using liposome technique are examples 1, 2 and 3 containing kinetin by general emulsification technique. It was confirmed that there is no problem in storage stability over time, compared to 3, and 4.
또한, 락탁애씨드를 키네틴의 용매로 사용한 실시예 5는 에틸알콜을 키네틴의 용매로 사용한 비교예 5에 비하여 경시보관 안전성에 문제가 없는 것으로 확인되었다.In addition, it was confirmed that Example 5 using lactac acid as the solvent of kinetin has no problems with the storage stability over time compared to Comparative Example 5 using ethyl alcohol as the solvent of kinetin.
상기 실시예에서 제조된 원료를 사용하여 아래 처방예와 같은 방법으로 제조하였다.Using the raw material prepared in the above Example was prepared in the same manner as in the formulation example below.
처방예 1.Prescription Example 1.
키네틴함유 리포좀을 함유한 화장료 중 화장수(스킨로션)의 처방예는 다음과 같다. 여기에서 키네틴함유 리포좀은 실시예 1의 것이다.A prescription example of a lotion (skin lotion) in a cosmetic containing a kinine-containing liposome is as follows. Wherein the kinetin-containing liposomes are from Example 1.
표 8. 본 발명에 따른 화장수(스킨로션)의 처방예Table 8. Prescription example of skin lotion (skin lotion) according to the present invention
제조방법Manufacturing method
제형예 1: 원료물질 11에 원료물질 2,3,4,8을 순서대로 투입하여 교반하여 용해시킨 후 원료물질 5를 60℃정도 가열하여 용해시킨 후 원료물질 10을 투입 교반하여 원료물질 11에 투입한다. 마지막으로 원료물질 1,6,7,9을 투입하여 충분히 교반한 뒤 고압균질기를 통과시킨 후 숙성시킨다.Formulation Example 1: Raw material 2,3,4,8 was added to raw material 11 in order to dissolve it, and then the raw material 5 was heated to 60 ° C. to dissolve, followed by input and stirring
비교제형예 1: 원료물질 11에 원료물질 2,3,4,8을 순서대로 투입하여 교반하여 용해시킨 후 원료물질 5를 60℃정도 가열하여 용해시킨 후 원료물질 10을 투입 교반하여 원료물질 11에 투입한다. 마지막으로 원료물질 6,7,9를 투입하여 충분히 교반한 뒤 고압균질기를 통과시킨 후 숙성시킨다.Comparative Example 1: Raw material 2,3,4,8 was added to raw material 11 in order, followed by stirring to dissolve it. Then, raw material 5 was heated to about 60 ° C. to dissolve, and then
처방예 2.Prescription Example 2.
키네틴함유 리포좀을 함유한 화장료 중 영양로션의 처방예는 다음과 같다. 여기에서 키네틴함유 리포좀은 실시예 1의 것이다.Prescription examples of nutritional lotions in cosmetics containing kinetin-containing liposomes are as follows. Wherein the kinetin-containing liposomes are from Example 1.
표 9. 본 발명에 따른 영양로션의 처방예Table 9. Prescription example of nutrition lotion according to the present invention
제조방법Manufacturing method
제형예 2 : 원료물질 2,3,4,5 및 6을 일정한 온도에서 균질화하여 비이온계 양친매성 지질이라 칭한다. 상기 비이온계 양친매성 지질과 원료물질 1,7,8 및 14를 혼합하고 일정한 온도에서 균질화하여 고압균질기를 통과하고 이어 원료물질 9를 일정한 온도에서 서서히 첨가하여 균질화한 후 다시 고압균질기에 재차 통과시킨다. 그리고 원료물질 10,11,12,13을 투입하여 분산시켜 안정화하고 숙성시킨다.Formulation Example 2: The raw materials 2,3,4,5 and 6 are homogenized at a constant temperature to be referred to as nonionic amphiphilic lipids. The nonionic amphiphilic lipid and the raw materials 1,7,8 and 14 are mixed and homogenized at a constant temperature and passed through a high pressure homogenizer, and then the raw material 9 is gradually added and homogenized at a constant temperature, and then passed through the high pressure homogenizer again. Let's do it. Then, the
비교제형예 2 : 원료물질 2,3,4,5 및 6을 일정한 온도에서 균질화하여 비이온계 양친매성 지질이라 칭한다. 상기 비이온계 양친매성 지질과 원료물질 7,8 및 14를 혼합하고 일정한 온도에서 균질화하여 고압균질기를 통과하고 이어 원료물질 9를 일정한 온도에서 서서히 첨가하여 균질화한 후 다시 고압균질기에 재차 통과시킨다. 그리고 원료물질 10,11,12,13을 투입하여 분산시켜 안정화하고 숙성시킨다.Comparative Formulation Example 2 The raw materials 2,3,4,5 and 6 were homogenized at a constant temperature to be referred to as nonionic amphiphilic lipids. The nonionic amphiphilic lipid and the raw materials 7,8 and 14 are mixed and homogenized at a constant temperature and passed through a high pressure homogenizer, and then the raw material 9 is gradually added and homogenized at a constant temperature, and then passed through the high pressure homogenizer again. Then, the
처방예 3Prescription Example 3
키네틴함유 리포좀을 함유한 화장료 중 영양크림의 처방예는 다음과 같다. 여기에서 키네틴함유 리포좀은 실시예 1의 것이다.Prescription example of nutrition cream among cosmetics containing kinetin-containing liposomes is as follows. Wherein the kinetin-containing liposomes are from Example 1.
표 10. 본 발명에 따른 영양크림의 처방예Table 10. Prescription example of nutrition cream according to the present invention
제조방법Manufacturing method
제형예 3 : 원료물질 2,3,4,5 및 6을 일정한 온도에서 균질화하여 비이온계 양친매성 지질이라 칭한다. 상기 비이온계 양친매성 지질과 원료물질 1,7,8 및 14를 혼합하고 일정한 온도에서 균질화하여 고압균질기를 통과하고 이어 원료물질 9를 일정한 온도에서 서서히 첨가하여 균질화한 후 다시 고압균질기에 재차 통과시 킨다. 그리고 원료물질 10,11,12,13을 투입하여 분산시켜 안정화하고 숙성시킨다.Formulation Example 3: Raw materials 2,3,4,5 and 6 are homogenized at a constant temperature to be referred to as nonionic amphiphilic lipids. The nonionic amphiphilic lipid and the raw materials 1,7,8 and 14 are mixed and homogenized at a constant temperature and passed through a high pressure homogenizer, and then the raw material 9 is gradually added and homogenized at a constant temperature, and then passed through the high pressure homogenizer again. Scream Then, the
비교제형예 3 : 원료물질 2,3,4,5 및 6을 일정한 온도에서 균질화하여 비이온계 양친매성 지질이라 칭한다. 상기 비이온계 양친매성 지질과 원료물질 7,8 및 14를 혼합하고 일정한 온도에서 균질화하여 고압균질기를 통과하고 이어 원료물질 9를 일정한 온도에서 서서히 첨가하여 균질화한 후 다시 고압균질기에 재차 통과시킨다. 그리고 원료물질 10,11,12,13을 투입하여 분산시켜 안정화하고 숙성시킨다.Comparative Formulation Example 3 The raw materials 2,3,4,5 and 6 were homogenized at a constant temperature to be referred to as nonionic amphiphilic lipids. The nonionic amphiphilic lipid and the raw materials 7,8 and 14 are mixed and homogenized at a constant temperature and passed through a high pressure homogenizer, and then the raw material 9 is gradually added and homogenized at a constant temperature, and then passed through the high pressure homogenizer again. Then, the
처방예 4.Prescription Example 4.
키네틴함유 리포좀을 함유한 화장료 중 맛사지 크림의 처방예는 다음과 같다. 여기에서 키네틴 리포좀은 실시예 1의 것이다.A prescription example of a massage cream among cosmetics containing kinetin-containing liposomes is as follows. Wherein the kinetin liposomes are from Example 1.
표 11. 본 발명에 따른 맛사지 크림의 처방예Table 11. Prescription examples of massage cream according to the present invention
제조방법Manufacturing method
제형예 4 : 원료물질 8,9,10,11,13,16을 혼합 교반하면서 80-85도 사이로 가열하여 제조부에 투입한 후 유화기를 작용시키고 원료물질 2,3,4,5,6,7,12를 80-85도 사이로 가열하여 투입한 뒤 유화한다. 유화가 끝나면 교반기를 이용하여 교반하면서 50도까지 냉각한 뒤 원료물질 14를 투입하고 45도까지 냉각한 뒤 원료물질 15를 투입하고 35도까지 냉각되면 원료물질 1을 투입한다. 25도까지 냉각한 뒤 숙성시킨다.Formulation Example 4: The
비교제형예 4 : 원료물질 8,9,10,11,13,16을 혼합교반하면서 80-85도 사이로 가열하여 제조부에 투입한 후 유화기를 작용시키고 원료물질 2,3,4,5,6,7,12를 80-85도 사이로 가열하여 투입한 뒤 유화한다. 유화가 끝나면 교반기를 이용하여 교반하면서 50도까지 냉각한 뒤 원료물질 14를 투입하고 45도까지 냉각한 뒤 원료물질 15를 투입하고 25도까지 냉각한 뒤 숙성시킨다.Comparative Formulation 4: The
처방예 5.Prescription Example 5.
키네틴함유 리포좀을 함유한 화장료 중 영양 에센스의 처방예는 다음과 같다. 여기에서 키네틴함유 리포좀은 실시예 1의 것이다.Prescription examples of nutritional essences in cosmetics containing kinetin-containing liposomes are as follows. Wherein the kinetin-containing liposomes are from Example 1.
표 12. 본 발명에 따른 영양 에센스의 처방예Table 12. Prescription Examples of Nutritional Essences According to the Present Invention
제조방법Manufacturing method
제형예 5 : 원료물질 2,3,4,5 및 6을 일정한 온도에서 균질화하여 비이온계 양친매성 지질이라 칭한다. 상기 비이온계 양친매성 지질과 원료물질 1,7,8 및 14를 혼합하고 일정한 온도에서 균질화하여 고압균질기를 통과하고 이어 원료물질 9를 일정한 온도에서 서서히 첨가하여 균질화한 후 다시 고압균질기에 재차 통과시킨다. 그리고 원료물질 10,11,12,13을 투입하여 분산시켜 안정화하고 숙성시킨다.Formulation Example 5: The raw materials 2,3,4,5 and 6 are homogenized at a constant temperature to be referred to as nonionic amphiphilic lipids. The nonionic amphiphilic lipid and the raw materials 1,7,8 and 14 are mixed and homogenized at a constant temperature and passed through a high pressure homogenizer, and then the raw material 9 is gradually added and homogenized at a constant temperature, and then passed through the high pressure homogenizer again. Let's do it. Then, the
비교제형예 5 : 원료물질 2,3,4,5 및 6을 일정한 온도에서 균질화하여 비이온계 양친매성 지질이라 칭한다. 상기 비이온계 양친매성 지질과 원료물질 7,8 및 14를 혼합하고 일정한 온도에서 균질화하여 고압균질기를 통과하고 이어 원료물질 9를 일정한 온도에서 서서히 첨가하여 균질화한 후 다시 고압균질기에 재차 통과시 킨다. 그리고 원료물질 10,11,12,13을 투입하여 분산시켜 안정화하고 숙성시킨다.Comparative Formulation 5: The raw materials 2,3,4,5 and 6 were homogenized at a constant temperature to be referred to as nonionic amphiphilic lipids. The nonionic amphiphilic lipid and the raw materials 7,8 and 14 are mixed and homogenized at a constant temperature and passed through a high pressure homogenizer, and then the raw material 9 is gradually added and homogenized at a constant temperature and passed again through a high pressure homogenizer. . Then, the
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060002557A KR100779819B1 (en) | 2006-01-10 | 2006-01-10 | The stability technology of using the technology of the liposome including kinetin which is effective for anti-wrinkle and the components of cosmetics including the liposome and the method of manufacturing the components. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060002557A KR100779819B1 (en) | 2006-01-10 | 2006-01-10 | The stability technology of using the technology of the liposome including kinetin which is effective for anti-wrinkle and the components of cosmetics including the liposome and the method of manufacturing the components. |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20070087874A KR20070087874A (en) | 2007-08-29 |
KR100779819B1 true KR100779819B1 (en) | 2007-11-28 |
Family
ID=38613652
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020060002557A KR100779819B1 (en) | 2006-01-10 | 2006-01-10 | The stability technology of using the technology of the liposome including kinetin which is effective for anti-wrinkle and the components of cosmetics including the liposome and the method of manufacturing the components. |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100779819B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2345806B1 (en) * | 2009-03-30 | 2011-07-22 | Universidad De Santiago De Compostela | NANOPARTICULAR SYSTEMS ELABORATED BASED ON ANIONIC POLYMERS TO MANAGE BIOACTIVE MOLECULES FOR COSMETIC USE. |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001031549A (en) | 1999-07-14 | 2001-02-06 | Pola Chem Ind Inc | Agent for reconstructing dermal collagen fiber bundle and cosmetic containing the same |
KR20010083712A (en) * | 2000-02-21 | 2001-09-01 | 김상회 | composition for liposome cosmetics and preparation method thereof |
KR20030025153A (en) * | 2001-09-19 | 2003-03-28 | 이보섭 | Derivatives of 6-substituted aminopurine with aliphatic or aromatic functional group, and cosmetics containing the same |
JP2004285032A (en) | 2003-03-20 | 2004-10-14 | Api Corporation | Water-dispersed preparation of kinetin and method for producing the same |
KR20040094691A (en) * | 2002-02-15 | 2004-11-10 | 아치 퍼스널 케어 프로덕츠, 엘.피. | Personal care composition containing leghemoglobin |
-
2006
- 2006-01-10 KR KR1020060002557A patent/KR100779819B1/en active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001031549A (en) | 1999-07-14 | 2001-02-06 | Pola Chem Ind Inc | Agent for reconstructing dermal collagen fiber bundle and cosmetic containing the same |
KR20010083712A (en) * | 2000-02-21 | 2001-09-01 | 김상회 | composition for liposome cosmetics and preparation method thereof |
KR20030025153A (en) * | 2001-09-19 | 2003-03-28 | 이보섭 | Derivatives of 6-substituted aminopurine with aliphatic or aromatic functional group, and cosmetics containing the same |
KR20040094691A (en) * | 2002-02-15 | 2004-11-10 | 아치 퍼스널 케어 프로덕츠, 엘.피. | Personal care composition containing leghemoglobin |
JP2004285032A (en) | 2003-03-20 | 2004-10-14 | Api Corporation | Water-dispersed preparation of kinetin and method for producing the same |
Also Published As
Publication number | Publication date |
---|---|
KR20070087874A (en) | 2007-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2727580B1 (en) | Astaxanthin-containing composition, method for manufacturing same, and cosmetic | |
CN110215416B (en) | Camellia oil oleogel emulsion and preparation method thereof | |
JP2023513098A (en) | Retinol-based inclusions, methods of making and using the same | |
KR100638170B1 (en) | Composition of oil phase having gemini type surfactant for stabilizing oil-soluble licorice extract and promoting its transepidermal absorption in whitening cosmetics and it's manufacturing method thereof | |
KR102692754B1 (en) | Cosmetic composition comprising Centella asiatica extract or Triterpene isolated therefrom with high content, and the method for preparing the same | |
CN114617785B (en) | Vesicle type carrier and preparation method thereof, cosmetic auxiliary material and preparation method thereof | |
KR100670440B1 (en) | The stability technology of using the technology of the liposome including adenosine & oil soluble licorice extract and the components of cosmetics including the liposome and the method of manufacturing the components | |
KR100737101B1 (en) | The stability technology of using the technology of the liposome including adenosine which is effective for anti-wrinkle and the components of cosmetics including the liposome and the method of manufacturing the components | |
JP2013199474A (en) | Skin care preparation and healthy skin cell activation agent | |
KR101618321B1 (en) | microcapsules containing natural ingredients and cosmetic composition comprising the microcapsules | |
KR101868481B1 (en) | Cosmetic composition for moisturizing skin with snowflake pattern and method of thereof | |
KR102395996B1 (en) | Method for preparing liposome to improve stability of carotenoid compound and functional cosmetic composition using the same | |
CN104379122B (en) | Cosmetics and emulsification composition containing Enoxolone derivative | |
KR100779819B1 (en) | The stability technology of using the technology of the liposome including kinetin which is effective for anti-wrinkle and the components of cosmetics including the liposome and the method of manufacturing the components. | |
JPS63255212A (en) | Skin cosmetic | |
KR0146221B1 (en) | Liquid crystal containing vitamin a palmitate and its cosmetic composition | |
KR20090040517A (en) | The components of cosmetics with the liposome including botanical extract which is effective for anti-acne and the method of manufacturing the components | |
KR101338503B1 (en) | Cosmetic composition comprising weighting agent | |
KR100522311B1 (en) | The stability technology of using the technology of nano spherical particles including perfluorodecalin which is effective for anti-wrinkle and the components of cosmetics including the nano spherical particles and the method of manufacturing the components. | |
CN111388340A (en) | Stable astaxanthin essence and preparation method thereof | |
KR20200049150A (en) | Oil-in-water type cosmetic composition with a low viscosity comprising a high content of oil | |
JP2019131524A (en) | Cosmetic and skin external preparation | |
JPH0899827A (en) | Skin external agent | |
KR101281820B1 (en) | Cosmetic composition in which sheen and softness of oil and setting property of hydrophilic polymer coexists, and the preparation method thereof | |
JP5329489B2 (en) | External preparation composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
E902 | Notification of reason for refusal | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121120 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20131111 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20141120 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20151006 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20161115 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20181120 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20191120 Year of fee payment: 13 |